an AIDS Vaccine????? WTF!!!

[Guest guest]

http://www.smartbrief.com/news/bio/storyDetails.jsp?issueid=077A8E36-

9FC5-4F2D-BA82-80829B1E8985 & copyid=724726CF-79BF-48BC-98F3-F90CAEDC9956

Experts weigh risks, benefits of testing AIDS vaccines in teens

BIO SmartBrief | 06/10/2008

An FDA advisory panel said HIV/AIDS trials in adolescents may be

appropriate in countries where adolescents are at higher risk for the

disease, but said the risks may outweigh the benefits for testing in

U.S. teens. The group is considering medical and ethical questions to

improve research guidelines for testing a variety of therapies in

clinical trials in children. Bloomberg (06/09)

[Guest guest]

This is most interesting in light of the very recent failures of AIDS vaccine trials:AIDS vaccine test halted after shots failPromising serum didn’t prevent infection in volunteers during key trial   updated 7:09 p.m. ET, Fri., Sept. 21, 2007TRENTON, N.J. - In a disappointing setback, a promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study.Merck & Co. said Friday that it is ending enrollment and vaccination of volunteers in the study, which was partly funded by the National Institutes of Health.It was a high-profile failure in the daunting quest to develop a vaccine to prevent AIDS. Merck’s vaccine was the farthest along, considered the most promising and was closely watched by experts in the field....Full article here:  http://www.msnbc.msn.com/id/20909432/On Jun 10, 2008, at 4:53 PM, izvestiaca wrote:http://www.smartbrief.com/news/bio/storyDetails.jsp?issueid=077A8E36-9FC5-4F2D-BA82-80829B1E8985 & copyid=724726CF-79BF-48BC-98F3-F90CAEDC9956Experts weigh risks, benefits of testing AIDS vaccines in teensBIO SmartBrief | 06/10/2008An FDA advisory panel said HIV/AIDS trials in adolescents may be appropriate in countries where adolescents are at higher risk for the disease, but said the risks may outweigh the benefits for testing in U.S. teens. The group is considering medical and ethical questions to improve research guidelines for testing a variety of therapies in clinical trials in children. Bloomberg (06/09)